Twist Bioscience (TWST) Total Liabilities (2017 - 2026)

Twist Bioscience (TWST) has reported Total Liabilities for 10 consecutive years, with $226.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Liabilities rose 37.05% year-over-year to $226.7 million in Q2 2026; TTM through Jun 2026 was $226.7 million, a 37.05% increase from a year earlier, with the FY2025 full-year figure at $168.9 million, up 19.25% from the prior year.
• Total Liabilities was $226.7 million for Q2 2026 at Twist Bioscience, up from $221.1 million in the prior quarter.
• Over five years, Total Liabilities peaked at $226.7 million in Q2 2026 and troughed at $141.6 million in Q3 2024.
• A 5-year average of $164.2 million and a median of $156.9 million in 2022 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 150.8% in 2022 and declined 12.75% in 2023, its largest moves.
• Over 5 years, Total Liabilities stood at $163.6 million in 2022, then decreased by 12.75% to $142.8 million in 2023, then climbed by 6.91% to $152.6 million in 2024, then gained by 19.23% to $182.0 million in 2025, then grew by 24.57% to $226.7 million in 2026.
• The last three Total Liabilities figures came in at $226.7 million (Q2 2026), $221.1 million (Q1 2026), and $182.0 million (Q4 2025), per Business Quant data.